AMOYTOP
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97180708
- Registration number
- 7347649
- Mark type
- Stylized text
- Filed
- 20 Dec 2021
- Published for opposition
- 28 Jun 2022
- Registered
- 02 Apr 2024
- Attorney of record
- Michael T. Smith
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; clinical medical reagents; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations, namely, antivirals; human growth hormone; medicinal preparations for the mouth and as sprays; nasal spray preparations; nutritional supplements
Owner
- XIAMEN AMOYTOP BIOTECH CO., LTD., Xiamen, Fujian, CN
- XIAMEN AMOYTOP BIOTECH CO., LTD., Xiamen, Fujian, CN
- XIAMEN AMOYTOP BIOTECH CO., LTD., Xiamen, Fujian, CN
Prosecution history
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 27 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jan 2024 — USE AMENDMENT FILED
- 13 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 03 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2023 — SOU EXTENSION 2 GRANTED
- 01 Jun 2023 — SOU EXTENSION 2 FILED
- 01 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 14 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2022 — SOU EXTENSION 1 GRANTED
- 12 Dec 2022 — SOU EXTENSION 1 FILED